Latest papers

FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.

Effect of rifampin on the pharmacokinetics of Axitinib (AG-013736) in Japanese and Caucasian healthy volunteers.

Serum-protein interactions with anticancer Ru(III) complexes KP1019 and KP418 characterized by EPR.

Secondary metabolites of Volvariella bombycina and their inhibitory effects on melanogenesis.

Axitinib (AG-013736).

HIF-1alpha and cancer therapy.

Compounds in clinical Phase III and beyond.

[Sound signals of danger activate the nitrergic system of the medial nucleus accumbens]

The guanylyl cyclase activator YC-1 directly inhibits the voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells.

Changes in characteristics of the specific binding of [3H]LY-278584, a 5-HT3-receptor antagonist, on differentiated NG108-15 cells.

[Oxidative modification of rat blood proteins after destruction capsaicin-sensitive nerve and change of nitric oxide level]

Axitinib--a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor.

Targeted molecular therapies in thyroid carcinoma.

A Versatile New Synthetic Route to 1 N -Hydroxyindazoles

Influence of ionising irradiation on clotrimazole in the solid state.

Preparation of polyfunctional indazoles and heteroarylazo compounds using highly functionalized zinc reagents.

Thrombin up-regulates vascular endothelial growth factor in experimental gliomas

Effect of 7-nitroindazole on the expression of intracellular calcium channels in the kidney of spontaneously hypertensive rats.

Nitric oxide-mediated toxicity in paraquat-exposed SH-SY5Y cells: a protective role of 7-nitroindazole.

Epidermal growth factor receptor pathway substrate 8 (Eps8) is a novel regulator of cell adhesion and the blood-testis barrier integrity in the seminiferous epithelium.